TipRanks

Kyle Guse Insider Profile

4 Followers
Kyle Guse, Director at Cerenome, holds 1.84K shares in Cerenome (Ticker: CNSY), holds 10.00K shares in Atossa Therapeutics (Ticker: ATOS).
tipranks
Kyle Guse

Kyle Guse
Cerenome (CNSY)
Director

Not Ranked
Kyle Guse has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23K
84.98%
15.02%
A breakdown of Kyle Guse's holdings

Insider Roles

Atossa Therapeutics
(ATOS)
CFO, Gen Counsel and Secretary
Cerenome
(CNSY)
Director
Roles that Kyle Guse holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kyle Guse

Kyle Guse's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cerenome
Oct 01, 2026
Director
Uninformative Buy
1.72K
$3.45K
Atossa Therapeutics
Nov 16, 2017
CFO, Gen Counsel and Secretary
Informative Buy
3.30K
$19.50K
List of latest transactions for each holding click on a transaction to see Kyle Guse's performance on stock

Kyle Guse insider profile FAQ

What is the percentage of profitable transactions made by Kyle Guse?
The percentage of profitable transactions made by Kyle Guse is ―.
    What is the average return per transaction made by Kyle Guse?
    The average return per transaction made by Kyle Guse is ―.
      What stocks does Kyle Guse hold?
      Kyle Guse holds: CNSY, ATOS stocks.
        What was Kyle Guse’s latest transaction?
        Kyle Guse latest transaction was an Uninformative Buy of $1.72K.
          What was Kyle Guse's most profitable transaction?
          Kyle Guse’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kyle Guse's role in Cerenome?
            Kyle Guse's role in Cerenome is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.